2012
DOI: 10.1016/j.rmr.2012.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Prise en charge thérapeutique des manifestations pulmonaires à la phase aiguë des leucémies aiguës myéloblastiques

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 84 publications
0
1
0
Order By: Relevance
“…Early management is associated with decreased mortality and might help in increasing the safety of diagnostic procedures such as bronchoscopy [ 28 , 55 ]. Although several infectious and non-infectious etiologies might be involved and might be intricate in these patients [ 55 63 ], a systematic diagnostic workup may lead to a high-probability diagnosis in 70–80 % of patients with ARF [ 55 63 ]. ARF of unknown origin is associated with a grim prognosis, suggesting diagnosis to be a major goal of management of these patients [ 56 58 , 64 ].…”
Section: Results and Recommendationsmentioning
confidence: 99%
“…Early management is associated with decreased mortality and might help in increasing the safety of diagnostic procedures such as bronchoscopy [ 28 , 55 ]. Although several infectious and non-infectious etiologies might be involved and might be intricate in these patients [ 55 63 ], a systematic diagnostic workup may lead to a high-probability diagnosis in 70–80 % of patients with ARF [ 55 63 ]. ARF of unknown origin is associated with a grim prognosis, suggesting diagnosis to be a major goal of management of these patients [ 56 58 , 64 ].…”
Section: Results and Recommendationsmentioning
confidence: 99%